Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CLGN
#3895
CollPlant Biotechnologies Ltd Ordinary Shares
0.5
7
-1.72%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.72%
Monthly Change
-70.62%
6 month change
-79.86%
Year Change
-83.71%
Previous Close
0.5
8
Open
0.5
7
Bid
Ask
Low
0.5
7
High
0.5
7
Volume
1
Markets
US Stock Market
Healthcare
CLGN
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
6.96 M
10.77 M
11.19 M
11.45 M
11.45 M
44.87 M
Valuation ratios
Enterprise value
—
163.33 M
109.87 M
42.61 M
29.33 M
345.14 M
Price to earnings ratio
—
818
-5.62
-9.76
-2.48
—
Price to sales ratio
—
12.52
317.35
6.29
80.07
—
Price to cash flow ratio
—
78.28
6.93
24.94
2.93
—
Price to book ratio
—
4.34
2.94
2.43
3.06
12.77
Enterprise value to EBITDA ratio
—
20.41
-19.03
11.33
-4.87
—
Profitability ratios
Return on assets %
0.53
0
0.45
0.21
0.89
—
Return on equity %
1.29
0.01
0.52
0.25
1.23
—
Return on invested capital %
13 K
1.94
419.83
-2 635.31
-1 658.9
—
Gross margin %
51.08
87.18
33.78
81.83
215.53
—
Operating margin %
91.23
0.42
5 718.06
68.55
3 349.71
—
EBITDA margin %
61.28
51.15
-1 931.44
34.33
-1 170.29
—
Net margin %
94.09
1.52
5 660.54
64.05
3 225.05
—
Liquidity ratios
Quick ratio
1.3
14.6
9.74
8.4
4.29
37.03
Current ratio
1.68
14.96
10.2
8.62
4.44
38.21
Inventory turnover
0.05
0.31
0.24
0.81
0.5
—
Asset turnover
0.57
0.5
0.01
0.3
0.02
—
Solvency ratios
Debt to assets ratio
—
0
1.15
—
—
—
Debt to equity ratio
—
0.01
1.34
—
—
—
Long term debt to total assets ratio
0.31
0
1.14
—
—
—
Long term debt to total equity ratio
0.75
0
1.33
—
—
—
Per share metrics
Operating cash flow per share
—
0.21
1.24
0.24
1.23
—
EBIT per share
—
0.6
-0.71
0.23
-0.62
—
EBITDA per share
—
0.67
-0.52
0.33
-0.53
—
Total debt per share
—
0.02
3.93
—
—
—
Cash per share
—
1.1
2.69
2.34
1.04
7.17
Net current asset value per share
—
3.77
2.87
2.46
1.15
10.25
Tangible book value per share
—
3.75
2.9
2.47
1.16
10.29
Working capital per share
—
3.52
2.59
2.17
0.89
9.17
Book value per share
—
3.77
2.93
2.49
1.18
10.36
News
CollPlant secures Korean patent for dermal filler technology
CollPlant launches BioFlex bioink kit for 3D bioprinting
CollPlant stock rating downgraded to Hold from Buy by D. Boral Capital
CollPlant Biotechnologies schedules annual and extraordinary meeting for December 31
Collplant ADR earnings missed by $0.41, revenue fell short of estimates
CollPlant shares edge down as Q3 revenue falls short of estimates
CollPlant expands North American distribution with new logistics hub
CollPlant’s bioink outperforms Matrigel in tissue formation study
Collplant stock plunges after advancing dermal filler to clinical trials
CollPlant advances photocurable dermal filler to clinical trials
Collplant ADR earnings beat by $0.37, revenue fell short of estimates
CollPlant names new VP to lead North American commercial operations